Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with
1Department of Internal Medicine 5, Tokyo Medical University, Inashiki, Ibaraki, Japan. s-kado@tokyo-med.ac.jp
Insights
Elevated levels of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) were observed in type 2 diabetes patients, suggesting their role in atherosclerosis development.
Area of Science:
- Endocrinology
- Cardiovascular Research
- Immunology
Background:
- Type 2 diabetes mellitus is associated with an increased risk of atherosclerosis.
- Adhesion molecules play a role in inflammatory processes and vascular disease.
- Understanding the role of specific adhesion molecules in diabetic complications is crucial.
Purpose of the Study:
- To investigate serum levels of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin in patients with type 2 diabetes.
- To determine the association between these adhesion molecules and diabetic macroangiopathy.
- To explore the relationship between glycemic control (hemoglobin A1c) and adhesion molecule levels in diabetes.
Main Methods:
- Serum samples were collected from 64 patients with type 2 diabetes and 40 control subjects.
- Concentrations of ICAM-1, VCAM-1, and E-selectin were measured using immunoassays.
- Statistical analyses, including multiple regression, were performed to assess associations.
Main Results:
- Serum ICAM-1 concentrations were significantly higher in diabetic patients compared to controls.
- Hemoglobin A1c was independently associated with serum ICAM-1 levels in diabetic patients.
- Serum VCAM-1 concentrations were elevated in diabetic patients with macroangiopathy compared to those without and controls.
- No significant difference in E-selectin levels was found among the groups.
Conclusions:
- Adhesion molecules, particularly ICAM-1 and VCAM-1, are elevated in type 2 diabetes.
- These adhesion molecules may contribute to the development of atherosclerosis in diabetic patients.
- VCAM-1 levels are associated with the presence of macroangiopathy in diabetes.
Abstract:
Serum levels of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in patients with type 2 diabetes mellitus (n = 64) and control subjects (n = 40) were studied. Serum ICAM-1 concentrations in diabetic patients were significantly higher than those of control subjects (378.2 +/- 70.0 versus 220.4 +/- 31.8 ng/ml, P < 0.01). By multiple regression analysis, hemoglobin A1c was independently associated with serum ICAM-1 concentration in patients with diabetes. The serum VCAM-1 concentration of diabetic patients with macroangiopathy was higher than those of patients without macroangiopathy and of control subjects (806.9 + 276.5 versus 639.0 +/- 146.0 (P < 0.01), and 652.1 +/- 146.9 ng/ml (P < 0.01), respectively). There was no difference in serum E-selectin concentration between diabetic patients with or without macroangiopathy and normal control subjects. These results suggest that adhesion molecules may contribute to the development of atherosclerosis in the diabetic state.
Related Concept Videos
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Selectins
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Diabetic Retinopathy


